InvestorsHub Logo
Post# of 252474
Next 10
Followers 832
Posts 119976
Boards Moderated 17
Alias Born 09/05/2002

Re: genisi post# 93823

Thursday, 04/08/2010 1:46:13 PM

Thursday, April 08, 2010 1:46:13 PM

Post# of 252474
Brazil is phasing out the use of similares, which are knockoffs of branded drugs that have not demonstrated bioequivalence to the corresponding brand. When similares are gone, the generic-drug market in Brazil will be a lot like the one in the US.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.